The stock is in a powerful, sustained uptrend, having gained 181.61% over the past year. As of the latest close at $451.40, the price is trading near the top of its 52-week range, approximately 93% of the way from its 52-week low of $158.48 toward its high of $484.71. This positioning near all-time highs reflects strong bullish momentum but also suggests the stock may be extended and vulnerable to a pullback or consolidation. The short-term momentum shows signs of cooling; the stock is down 3.66% over the past month, diverging from its explosive 73.02% gain over the past three months. This 1-month pullback could represent a healthy consolidation after the parabolic move from late April to early May, where the price surged from around $320 to nearly $480. The stock exhibits significant volatility, with a beta of 1.297, indicating it is approximately 30% more volatile than the broader market, which is a critical consideration for risk management. Key technical support is anchored at the 52-week low of $158.48, though more immediate support lies near the $400-$420 zone where the recent consolidation began. The primary resistance is the 52-week high of $484.71; a decisive breakout above this level could signal a continuation of the primary uptrend, while a failure and reversal could indicate a double-top formation and a more significant correction.

MYRG is demonstrating robust revenue growth and a strong recovery in profitability. For Q4 2025, the company reported revenue of $973.5 million, representing a year-over-year growth of 17.32%. This growth is part of a clear multi-quarter acceleration, as evidenced by sequential quarterly revenue increases from $833.62 million in Q1 2025 to the latest figure. The company's net income for the quarter was $36.5 million, translating to a net margin of 3.75%, a significant improvement from the 1.92% net margin in Q4 2024. Profitability metrics show a positive trajectory; the gross margin for Q4 2025 was 11.43%, and the operating margin was 4.76%. The trailing twelve-month free cash flow is a healthy $232.2 million, indicating the business is generating substantial cash from operations. The balance sheet appears solid with a conservative debt-to-equity ratio of 0.16 and a current ratio of 1.33, suggesting adequate short-term liquidity. The return on equity (ROE) of 17.93% is strong and reflects efficient use of shareholder capital. The company's cash generation, evidenced by the $232.2 million in TTM FCF, provides ample internal funding for growth initiatives like the recent acquisitions, reducing reliance on external financing.